menu search

Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights

Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
BOSTON, May 09, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, provided a business and financial update for the first quarter 2023. Recent Business Highlights CUE-101 abstract accepted for presentation at […] The post Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Hig... Read More
Posted: May 9 2023, 20:35
Author Name: forextv
Views: 081771

Search within

Pages Search Results: